Assessment of vasomotor endothelial function in patients with diabetes mellitus type 1 at different stages of diabetic nephropathy

被引:0
作者
Shestakova, MV [1 ]
Yarek-Martynov, IR
Ivanishina, NS
Dedov, II
机构
[1] Russian Acad Med Sci, Endocrinol Res Ctr, Moscow, Russia
[2] Minist Publ Hlth Russia, Prevent Med State Res Ctr, Moscow, Russia
关键词
diabetes mellitits type 1; diabetic nephropathy; vasomotor function of the endothelium; endothelitis; reactive hyperemia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To study a vasomotor endothelial function in patients with diabetes mellitus (DM) type I at different stages of diabetic nephropathy (DN). Material and methods. Twenty six patients with DM type I (I I males and 15 females, mean age 25.9 +/- 4.3 years, mean history of DM 12.9 +/- 3.4 years) entered the study. They were divided into 4 groups: group I -without renal affection, group 2 - with microalbuminuria (MAU), group 3 - with proteinuria (PU), group 4 - with chronic renal failure (CRF). The control group consisted of 7 healthy volunteers. Endothelium-dependent vasodilation (EDVD) was studied in the test with reactive hyperemia provoked by 4-5 min occlusion of the brachial artery by pneumocollar and subsequent assessment of arterial diameter changes after decompression using high-resolution ultrasound dopplerography. Results. Reactive hyperemia resulted in dilation of the artery in all the examinees. This dilation was maximal on second 30 after removal of the collar in the controls, group 2, 3 and 4 and reached 9.2 +/- 2.9, 9.63 +/- 3.62, 725 +/- 5.23 and 4.42 +/- 4.05%, respectively. Resting bloodflow velocity was similar in all the groups and-rose maximally by 95-150%. To estimate EDVD of the brachial artery more precisely, the coefficient of endothelial sensitivity to shift tension was calculated. It made up 0.084 +/- 0.04 (control group), 0.0825 +/- 0.08 (group 1), 0.138 +/- 0.07 (group 2), 0.067 +/- 0.05 (group 3) and 0.052 +/- 0.04 (group 4). Conclusion. At the earliest stage of DN (stage MAU), EDVD is not affected as maximal vasodilation of the brachial artery and endothelial sensitivity to shift tension do not differ from the control values. This means that the stage of MA U is reversible in early treatment, but PU and CRF are not reversible stages associated with depletion of endothelial cells and loss of sensitivity to changing hemodynamic conditions.
引用
收藏
页码:17 / 21
页数:5
相关论文
共 50 条
  • [21] Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus
    Song, Ki-Ho
    Jeong, Jee-Sun
    Kim, Mee Kyoung
    Kwon, Hyuk-Sang
    Baek, Ki-Hyun
    Ko, Seung-Hyun
    Ahn, Yu-Bae
    JOURNAL OF DIABETES INVESTIGATION, 2019, 10 (03) : 745 - 752
  • [22] The Search for Molecular Prognostic Markers of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus
    Ibragimov, V. M.
    Sarvilina, I. V.
    Batiushin, M. M.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2016, 6 (01) : 65 - 69
  • [23] ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy
    Sulaj, Alba
    Kopf, Stefan
    Grone, Elisabeth
    Grone, Hermann-Josef
    Hoffmann, Sigrid
    Schleicher, Erwin
    Haring, Hans-Ulrich
    Schwenger, Vedat
    Herzig, Stephan
    Fleming, Thomas
    Nawroth, Peter P.
    von Bauer, Rudiger
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (06) : 1058 - 1065
  • [24] Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in Type 1 diabetes mellitus
    Moczulski, DK
    Scott, L
    Antonellis, A
    Rogus, JJ
    Rich, SS
    Warram, JH
    Krolewski, AS
    DIABETIC MEDICINE, 2000, 17 (02) : 111 - 118
  • [25] Polymorphism of the angiotensinogen gene and genetic predisposition to diabetic nephropathy in diabetes mellitus type 1
    Chistyakov, DA
    Turakulov, RI
    Kondrat'ev, YY
    Shestakova, MV
    Nosikov, VV
    Dedov, II
    Debabov, VG
    MOLECULAR BIOLOGY, 1999, 33 (02) : 177 - 179
  • [26] Midkine: Utility as a Predictor of Early Diabetic Nephropathy in Children with Type 1 Diabetes Mellitus
    Metwalley, Kotb Abbass
    Farghaly, Hekma Saad
    Gabri, Magda Farghali
    Abdel-Aziz, Safwat Mohamed
    Ismail, Asmaa Mohamed
    Raafat, Duaa Mohamed
    Elnakeeb, Islam Fathy
    JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2021, 13 (03) : 293 - 299
  • [27] Sirtuin 1 rs7069102 polymorphism is associated with diabetic nephropathy in patients with type 2 diabetes mellitus
    Letonja, Jernej
    Zavrsnik, Matej
    Makuc, Jana
    Seruga, Maja
    Peterlin, Ana
    Cilensek, Ines
    Petrovic, Danijel
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (05) : 642 - 646
  • [28] Dyslipidaemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy
    Martínez-Castelao, A
    Ramos, R
    González, MT
    Castiñeiras, MJ
    NEFROLOGIA, 2002, 22 : 51 - 58
  • [29] Aldose reductase gene polymorphism is associated with progression of diabetic nephropathy in Japanese patients with type 1 diabetes mellitus
    Yamamoto, T
    Sato, T
    Hosoi, M
    Yoshioka, K
    Tanaka, S
    Tahara, H
    Nishizawa, Y
    Fujii, S
    DIABETES OBESITY & METABOLISM, 2003, 5 (01) : 51 - 57
  • [30] Role of ENPP1 Gene Variants in the Susceptibility to Diabetic Nephropathy in Patients with type 2 Diabetes Mellitus
    Faraji, Niloofar
    Abbaspour, Saima
    Ajamian, Farzam
    Keshavarz, Parvaneh
    BIOCHEMICAL GENETICS, 2023, 61 (06) : 2710 - 2723